Celltech announces appointment of new chief executive officer
Dr. Ando succeeds Dr. Peter Fellner, who has been CEO of Celltech since 1990. Dr. Fellner will take up the position of Chairman with immediate effect, following the retirement of Mr. John Jackson.
Dr. Fellner commented, 'In appointing Dr. Ando as Celltech's new Chief Executive Officer, we have selected an individual who not only has an exceptional track record in drug discovery and development appropriate for a leading R&D based biotechnology company, but one who also has extensive business experience and capabilities to guide Celltech through its next phase of growth. We are delighted that someone of his stature will be taking up the leadership of Celltech.
Goran and I have worked closely together during the past two years, in the context of Celltech's landmark partnership with Pharmacia, and he brings to Celltech qualities which I believe will accelerate the Company's development as a global biotechnology leader'.
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.